TY  - GEN
AU  - Yang,Yaqiong
AU  - Jiang,Hua
AU  - Gao,Huiping
AU  - Kong,Juan
AU  - Zhang,Pengwei
AU  - Hu,Suwen
AU  - Shi,Bizhi
AU  - Zhang,Pengfei
AU  - Yao,Ming
AU  - Li,Zonghai
TI  - The monoclonal antibody CH12 enhances the sorafenib-mediated growth inhibition of hepatocellular carcinoma xenografts expressing epidermal growth factor receptor variant III
SN  - 1476-5586
PY  - 2012///1113
KW  - Animals
KW  - Antibodies, Monoclonal
KW  - pharmacology
KW  - Antineoplastic Agents
KW  - administration & dosage
KW  - Apoptosis
KW  - drug effects
KW  - Benzenesulfonates
KW  - Carcinoma, Hepatocellular
KW  - drug therapy
KW  - Cell Line, Tumor
KW  - Cell Proliferation
KW  - Drug Resistance, Neoplasm
KW  - genetics
KW  - Drug Synergism
KW  - ErbB Receptors
KW  - antagonists & inhibitors
KW  - Gene Expression Regulation, Neoplastic
KW  - Humans
KW  - Liver Neoplasms
KW  - MAP Kinase Signaling System
KW  - Mice
KW  - Mice, Nude
KW  - Neovascularization, Pathologic
KW  - Niacinamide
KW  - analogs & derivatives
KW  - Phenylurea Compounds
KW  - Protein Kinase Inhibitors
KW  - Proto-Oncogene Proteins c-akt
KW  - metabolism
KW  - Pyridines
KW  - STAT3 Transcription Factor
KW  - Sorafenib
KW  - Xenograft Model Antitumor Assays
N1  - Publication Type: Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1593/neo.12328
ER  -